Andoy, Rave Cluth John .

HRN: 11-22-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2023
CEFUROXIME 750MG (VIAL)
10/05/2023
10/11/2023
IVT
750mg
Q8hrs
UTI; Dengue Severe
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: